As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: February 27, 2012
Scientists experimented on mice using a chemical to maintain the supply of blood glucose to brain cells
by The Mirror
Alzheimer’s disease could be cured by preventing low blood sugar in the brain, scientists revealed yesterday. They experimented on mice using a chemical to maintain the supply of blood glucose to brain cells – and found it helped to stop dementia.
Chemical biologist Prof David Vocadlo and his team at the Simon Fraser University in Canada, genetically programmed mice to develop Alzheimer’s before injecting them with the chemical called Thiamet-G. He said the study provided fresh insights into dementia and added: “These results could help us to hinder progression ofAlzheimer’s disease.”
Alzheimer’s is the most common form of dementia and there is no known cure for it. By 2020, the number of sufferers worldwide could double to 42 million. It causes the brain to shrink and leads to long-term memory loss and mental confusion.
Current treatments can only ease the symptoms temporarily. The cause is not fully understood but scientists believe the main factors are plaque on the outside of neurons in the brain and protein “tangles” inside them.
The Canadian experiment found the chemical slowed formation of these proteins and reduced destruction of brain cells. In particular, it prevented removal of sugar from the neurons, which send messages between brain cells.
Picture Source: Toronto Sun
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.